ClinicalTrials.govpublic full text
Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy
spinal muscular atrophy, spinal muscular atrophy (sma), valproic acid, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893851
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.